KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 111 filers reported holding KRYSTAL BIOTECH INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $348,812 | +9.1% | 3,007 | +10.4% | 0.00% | 0.0% |
| Q2 2023 | $319,798 | +14.9% | 2,724 | -21.6% | 0.00% | 0.0% |
| Q1 2023 | $278,289 | +8.1% | 3,476 | +7.0% | 0.00% | 0.0% |
| Q4 2022 | $257,418 | -16.7% | 3,249 | -26.6% | 0.00% | 0.0% |
| Q3 2022 | $309,000 | +8.0% | 4,428 | +1.7% | 0.00% | 0.0% |
| Q2 2022 | $286,000 | -30.8% | 4,356 | -29.8% | 0.00% | -50.0% |
| Q1 2022 | $413,000 | -3.3% | 6,201 | +4.8% | 0.00% | 0.0% |
| Q4 2021 | $427,000 | +72.9% | 5,916 | +25.1% | 0.00% | +100.0% |
| Q3 2021 | $247,000 | -21.1% | 4,730 | +2.8% | 0.00% | -50.0% |
| Q2 2021 | $313,000 | -52.6% | 4,601 | -46.3% | 0.00% | -50.0% |
| Q1 2021 | $660,000 | +89.7% | 8,572 | +47.6% | 0.00% | +33.3% |
| Q4 2020 | $348,000 | +126.0% | 5,808 | +62.0% | 0.00% | +200.0% |
| Q3 2020 | $154,000 | +4.1% | 3,586 | +0.3% | 0.00% | -50.0% |
| Q2 2020 | $148,000 | +2.8% | 3,575 | +7.2% | 0.00% | 0.0% |
| Q1 2020 | $144,000 | -8.3% | 3,334 | +26.3% | 0.00% | 0.0% |
| Q4 2019 | $157,000 | – | 2,639 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 895,000 | $31,079,000 | 9.72% |
| Knoll Capital Management, LLC | 120,212 | $4,174,000 | 3.82% |
| S Squared Technology, LLC | 67,533 | $2,345,000 | 2.07% |
| Redmile Group, LLC | 1,078,300 | $37,444,000 | 1.25% |
| EAM Investors, LLC | 87,914 | $3,053,000 | 0.81% |
| Consonance Capital Management LP | 224,090 | $7,782,000 | 0.77% |
| EAM Global Investors LLC | 41,329 | $1,435,000 | 0.70% |
| SPHERA FUNDS MANAGEMENT LTD. | 117,625 | $4,085,000 | 0.63% |
| GARNET EQUITY CAPITAL HOLDINGS, INC. | 28,000 | $972,000 | 0.62% |
| Atika Capital Management LLC | 58,319 | $2,026,000 | 0.43% |